2008•Clinical MedicineRequires access

Curative effect of diltiazem for treatment of patients with ischemic cardiomyopathy and angina pectoris

Shen Wenxiang

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy of taking diltiazem orally for patients with ischemic cardiomyopathy and angina pectoris.Methods Seventy-two patients with ischemic cardiomyopathy and angina pectoris were randomly divided into two groups.Thirty patients in control group were treated with normal ways and means,42 patients in diltiazem group were given diltiazem 15-30 mg orally every 6 hours for two weeks,on the basis of normal treatment.The symptom,electrocardiogram,heart rate,blood pressure and heart function were observed in two groups.Results The clinical total effective rate was higher in diltiazem group than that in control group(P0.05).There was no obvious difference in blood pressure and heart function between the two groups(P0.05).The heart rate in diltiazem group was lower than that in control group(P0.05).Conclusion Taking diltiazem orally for patients with ischemic cardiomyopathy and angina pectoris is effective.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of taking diltiazem orally for patients with ischemic cardiomyopathy and angina pectoris.Methods Seventy-two patients with ischemic cardiomyopathy and angina pectoris were randomly divided into two groups.Thirty patients in control group were treated with normal ways and means,42 patients in diltiazem group were given diltiazem 15-30 mg orally every 6 hours for two weeks,on the basis of normal treatment.The symptom,electrocardiogram,heart rate,blood pressure and heart function were observed in two groups.Results The clinical total effective rate was higher in diltiazem group than that in control group(P0.05).There was no obvious difference in blood pressure and heart function between the two groups(P0.05).The heart rate in diltiazem group was lower than that in control group(P0.05).Conclusion Taking diltiazem orally for patients with ischemic cardiomyopathy and angina pectoris is effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of taking diltiazem orally for patients with ischemic cardiomyopathy and angina pectoris.Methods Seventy-two patients with ischemic cardiomyopathy and angina pectoris were randomly divided into two groups.Thirty patients in control group were treated with normal ways and means,42 patients in diltiazem group were given diltiazem 15-30 mg orally every 6 hours for two weeks,on the basis of normal treatment.The symptom,electrocardiogram,heart rate,blood pressure and heart function were observed in two groups.Results The clinical total effective rate was higher in diltiazem group than that in control group(P0.05).There was no obvious difference in blood pressure and heart function between the two groups(P0.05).The heart rate in diltiazem group was lower than that in control group(P0.05).Conclusion Taking diltiazem orally for patients with ischemic cardiomyopathy and angina pectoris is effective.

Key concepts: Diltiazem, Medicine, Angina, Cardiology, Internal medicine, Cardiomyopathy, Ischemic cardiomyopathy, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
Curative effect of diltiazem for treatment of patients with ischemic cardiomyopathy and angina pectoris — Research Paper | ScholarLens